Intercept to go back to FDA with its NASH treatment application
Reuters· 41 分鐘前The company is seeking approval for obeticholic acid to treat fibrosis or scarring associated with nonalcoholic steatohepatitis ...
Our oddest photos of the week
Reuters· 2 小時前Reuters / Tuesday, July 05, 2022 Activists from the People for the Ethical Treatment of Animals ...
Why Covid is still a pandemic, says Dr. Jha: 'We got the biological science right, but we ...
CNBC· 2 小時前The problem, Jha said at the Aspen Ideas Festival in Aspen, Colorado, last week, is that those ...
EXCLUSIVE WTO faces new battle over COVID tests, drugs
Reuters· 2 小時前Less than a month after a hard-won deal was reached on a partial waiver of intellectual ...
The end of time wasting? MLS kick off revolutionary rule experiment | Goal.com
Goal.com· 3 小時前To eliminate these kinds of unsporting behaviour, Major League Soccer (MLS) has come up with a ...
Abortion Pill Won’t Be the Only One Restricted by State Bans
Bloomberg· 5 小時前Patients are already encountering obstacles getting other needed medicines. Pharma companies ...
How startups are dealing with the hardest fundraising climate in more than a decade
CNBC· 5 小時前When Cube CEO Christina Ross kicked off fundraising efforts for her financial planning software ...
Public hospitals daily update on COVID-19 cases
HKSAR Government Press Releases· 5 小時前Among the patients staying in isolation facilities, 324 patients are in isolation wards, 15 patients are in second-tier ...
DH investigates suspected case of sepsis
HKSAR Government Press Releases· 5 小時前The Department of Health (DH) is today (July 7) investigating a suspected case of sepsis after receiving intravenous injection ...
Intercept to resubmit NASH treatment application for FDA review
Reuters· 5 小時前Intercept Pharmaceuticals said on Thursday it would resubmit its application for nonalcoholic steatohepatitis (NASH) < ...
